Research · the live claims database
Every listing here is ruled phrase by phrase against the full standards list in force at its scan. Rulings, not scraped copy. This is the benchmark your audit ranks you against.
The claims database
Updated 14 Sep 2026Ruled against standards drawn from FDA and FTC rules, Health Canada, and Amazon and Meta policy.
Phrases that fail most
If your listing uses one of these, you are not being original, you are being counted. Each is struck through, exactly as it would appear in your report.
Brand counts are distinct brands, among the 587 ruled, that carry the phrase or a direct variant.
The enforcement record
Every event below changed what a supplement listing may say, and each one is already reflected in the standards.
Supplement, OTC and functional-food marketers received formal Notice of Penalty Offenses: unsubstantiated claims now carry $53,088 per violation, per statutory schedule.
Plaintiffs’ firms mine listings under state consumer-protection and false-advertising statutes. The same phrase that fails an FDA standard is the exhibit.
Trade press reported that from 31 March 2026 Amazon began requiring detail-page content to align with the Supplement Facts panel, enforced automatically across titles, descriptions and images. Amazon has not published the policy, so this is reported rather than official.
The commission sued over supplements marketed as treating depression, anxiety and ADHD, the exact named-condition territory most listings drift into.
Amazon’s published supplement policy names GLP-1 and prescription-equivalence framings as prohibited outright, alongside disease claims and disease terms in backend keywords.
Updated as letters post · free to cite
The full enforcement tracker
Every dated action above, plus each FDA warning letter as it posts, with its source and the standard family it maps to.
Sources: FTC penalty schedule, FDA warning-letter database, Amazon seller policy, public litigation record.
Category coverage
The share of ruled listings that fail our standards outright. Stress is the least compliant shelf in the store, with gut and digestion close behind. Every category has a screenshot-ready scorecard with its scan window and standards version printed on it.
Every category sits in the category claims-risk index, published with its method, its date and a line to cite it by.
Fail means at least one Critical or High finding on the live listing. Based on 1,524 listings across sleep, gut, stress, immune, cognitive, joint, sports and energy.
Inside the 6,419 findings
Severity across every finding flagged to date. The Critical share concentrates in a handful of brands rather than spreading evenly.
By severity · 6,419 findings
615 Critical findings sit across 587 brands, which is why 39% of brands carry at least one: Critical exposure clusters, it does not spread evenly.
The database in four numbers
Counts from the live database · updated 14 Sep 2026
The peer benchmark
Every audit includes your exposure score and your position against the ruled listings in your category, before and after the rewrites go live.
Acquirers and retail buyers ask where a brand sits. This is the only database that can answer with rulings instead of impressions.
Briefings
Working analyses drawn from the database. Available to clients on request. Press and researchers may cite headline figures with attribution to Claims Verified.
Published quarterly · free to cite
The State of Supplement Claims
The full quarterly report: the verdict split, fail rates by category, the ten most-flagged phrases quoted verbatim from live listings, and the enforcement record behind them. Brands are never named.
Briefing 01
The “GMP certified” problem
One of the most-ruled phrases in the database is a certification claim almost no brand can substantiate as written. Why it survives, and the compliant form that converts as well.
On request · clients and press
Briefing 02
Backend keywords are in scope
Amazon’s policy reaches fields shoppers never see. What we found in listings that stuffed condition terms into backend search.
On request · clients and press
Briefing 03
The GLP-1 gold rush
“Nature’s Ozempic” and prescription-equivalence copy: Amazon’s published supplement policy names GLP-1 drugs, and what that means for weight-loss claims.
On request · clients and press
Briefing 04
What AI tells shoppers about you
ChatGPT, Claude, Gemini, Perplexity, Grok and Amazon’s Rufus answer for your brand whether you like the answer or not. How ruled claims spread into AI shopping answers, tested monthly.
On request · clients and press
Cite usJournalists and researchers: every headline figure on this page is free to use. Credit “Claims Verified” and link here. Want to know how a number was built, or need a full briefing? Email the research team.
audit@claimsverified.org →Method
Pharmacist-in-the-loop
See where I sit: free check